A non-viral CRISPR/Cas9 delivery system for therapeutically targeting HBV DNA and pcsk9 in vivo

Jiang, Chao, Mei, Miao, Li, Bin, Zhu, Xiurui, Zu, Wenhong, Tian, Yujie, Wang, Qiannan, Guo, Yong +2 more·2017·Cell Research
DOI 10.1038/cr.2017.16

Cited by (296)

Items 101–200 of 296

  1. Chemotherapy drugs derived nanoparticles encapsulating mRNA encoding tumor suppressor proteins to treat triple-negative breast cancer
    Zhang, Chengxiang, Zhang, Xinfu, Zhao, Weiyu, Zeng, Chunxi, Li, Wenqing, Li, Bin, Luo, Xiao, Li, Junan, Jiang, Justin, Deng, Binbin et al. · 2019 · Nano Research
  2. CRISPR-delivery particles targeting nuclear receptor–interacting protein 1 (Nrip1) in adipose cells to enhance energy expenditure
    Yuefei Shen, Jessica L. Cohen, Sarah M. C. Nicoloro, Mark Kelly, Batuhan Yenilmez, Felipe dos Santos Henriques, Emmanouela Tsagkaraki, Yvonne J. K. Edwards, Xiaodi Hu, Randall H. Friedline et al. · 2018 · Journal of Biological Chemistry
  3. CRISPR/Cas9-Based Antiviral Strategy: Current Status and the Potential Challenge
    Choong-Ho Lee · 2019 · Molecules
  4. Delivery Approaches for Therapeutic Genome Editing and Challenges
    Ilayda Ates, Tanner Rathbone, Callie Stuart, P. Hudson Bridges, Renee N. Cottle · 2020 · Genes
  5. Nanobiomaterial vectors for improving gene editing and gene therapy
    Shao Wei Hu, Tao Ding, Honghai Tang, Huiping Guo, Wenguo Cui, Yilai Shu · 2023 · Materials Today
  6. Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies
    Akbar Hasanzadeh, Masoomeh Alamdaran, Sepideh Ahmadi, Helena Nourizadeh, Mohammad Aref Bagherzadeh, Mirza Ali Mofazzal Jahromi, Perikles D. Simon, Mahdi Karimi, Michael Richard Hamblin · 2021 · Journal of Controlled Release
  7. The potential and challenges of CRISPR-Cas in eradication of hepatitis B virus covalently closed circular DNA
    Hung‐Chih Yang, Pei‐Jer Chen · 2017 · Virus Research
  8. Intelligent nanotherapeutic strategies for the delivery of CRISPR system
    Chao Chen, Wu Zhong, Shiyu Du, Yayao Li, Yunfei Zeng, Kunguo Liu, Jingjing Yang, Xiaoxiang Guan, Xin Han · 2022 · Acta Pharmaceutica Sinica B
  9. Lipid Nanoparticles for Delivery of CRISPR Gene Editing Components
    Fan Wu, Nei Li, Yi Xiao, Rohan Palanki, Hannah M. Yamagata, Michael J. Mitchell, Xuexiang Han · 2025 · Small Methods
  10. CRISPR-Cas Targeting of Host Genes as an Antiviral Strategy
    Shuliang Chen, Xiao Yu, Deyin Guo · 2018 · Viruses
  11. Non-viral and viral delivery systems for CRISPR-Cas9 technology in the biomedical field
    Zhiyao He, Ke Men, Zhou Qin, Yang Yang, Ting Xu, Yu-Quan Wei · 2017 · Science China Life Sciences
  12. High‐Precision Synthesis of RNA‐Loaded Lipid Nanoparticles for Biomedical Applications
    Hanjin Seo, Leekang Jeon, Jaeyeong Kwon, Hyomin Lee · 2023 · Advanced Healthcare Materials
  13. Systemic delivery of CRISPR/Cas9 to hepatic tumors for cancer treatment using altered tropism of lentiviral vector
    Sungjin Lee, Young-Youb Kim, Hyung Jun Ahn · 2021 · Biomaterials
  14. Cell Subtypes Within the Liver Microenvironment Differentially Interact with Lipid Nanoparticles
    Cory D. Sago, Brandon R. Krupczak, Melissa P. Lokugamage, Zubao Gan, James E. Dahlman · 2019 · Cellular and Molecular Bioengineering
  15. Strategies for the CRISPR-Based Therapeutics
    Bin Li, Yuyu Niu, Weizhi Ji, Yizhou Dong · 2019 · Trends in Pharmacological Sciences
  16. CRISPR/Cas technology as a promising weapon to combat viral infections
    Carmen Escalona‐Noguero, María López‐Valls, Begoña Sot · 2021 · BioEssays
  17. PCSK9 in metabolism and diseases
    Ajoolabady, Amir, Pratico, Domenico, Mazidi, Mohsen, Davies, Ian G., Lip, Gregory Y.H., Seidah, Nabil, Libby, Peter, Kroemer, Guido, Ren, Jun · 2025 · Metabolism
  18. Microfluidic synthesis of nanomaterials for biomedical applications
    Yanjuan Huang, Chao Liu, Qiang Feng, Jiashu Sun · 2023 · Nanoscale Horizons
  19. Synthesis and Evaluation of pH-Sensitive Multifunctional Lipids for Efficient Delivery of CRISPR/Cas9 in Gene Editing
    Da Sun, Zhanhu Sun, Hongfa Jiang, Amita M. Vaidya, Rui Xin, Nadia R. Ayat, Andrew L. Schilb, Peter L. Qiao, Zheng Han, Amirreza Naderi et al. · 2018 · Bioconjugate Chemistry
  20. Stimulus-Responsive Smart Nanoparticles-Based CRISPR-Cas Delivery for Therapeutic Genome Editing
    Muhammad Naeem, Mubasher Zahir Hoque, Muhammad Ovais, Chanbasha Basheer, Irshad Ahmad · 2021 · International Journal of Molecular Sciences
  21. Transfection by cationic gemini lipids and surfactants
    Mark Damen, A. Groenen, Stijn F. M. van Dongen, Roeland J. M. Nolte, Bob J. Scholte, Martinus C. Feiters · 2018 · MedChemComm
  22. Tumor targeted genome editing mediated by a multi-functional gene vector for regulating cell behaviors
    Boya Liu, Xiaoyan He, Ren‐Xi Zhuo, Si‐Xue Cheng · 2018 · Journal of Controlled Release
  23. Moving toward genome-editing therapies for cardiovascular diseases
    Kiran Musunuru · 2022 · Journal of Clinical Investigation
  24. CRISPR-Cas13a mediated targeting of hepatitis C virus internal-ribosomal entry site (IRES) as an effective antiviral strategy
    Muhammad Usman Ashraf, Hafiz Muhammad Salman, Muhammad Farhan Khalid, Muhammad Haider Farooq Khan, Saima Anwar, Samia Afzal, Muhammad Idrees, Safee Ullah Chaudhary · 2021 · Biomedicine & Pharmacotherapy
  25. Co-delivery of Cas9 mRNA and guide RNAs edits hepatitis B virus episomal and integration DNA in mouse and tree shrew models
    Junzhu Yi, Xinlin Lei, Fangteng Guo, Qiubing Chen, Xueyong Chen, Kaitao Zhao, Chengliang Zhu, Xiaoming Cheng, Jiangwei Lin, Hao Yin et al. · 2023 · Antiviral Research
  26. CRISPR/Cas9 application in cancer therapy: a pioneering genome editing tool
    Sadegh Shojaei Baghini, Zhanna R. Gardanova, Saeme Azizi Hassan Abadi, Burhan Abdullah Zaman, Ahmet İlhan, Navid Shomali, Ali Adili, Roozbeh Moghaddar, Amirhossein Fakhre Yaseri · 2022 · Cellular & Molecular Biology Letters
  27. Appropriate Delivery of the CRISPR/Cas9 System through the Nonlysosomal Route: Application for Therapeutic Gene Editing
    Hang Yin, Xiaoling Yuan, Lihua Luo, Yichao Lu, Bing Qin, Junlei Zhang, Yingying Shi, Chunqi Zhu, Jie Yang, Xiang Li et al. · 2020 · Advanced Science
  28. Translating CRISPR-Cas Therapeutics: Approaches and Challenges
    Lavina Sierra Tay, Nathan D. Palmer, Rebecca Panwala, Wei Leong Chew, Prashant Mali · 2020 · The CRISPR Journal
  29. Present and Future Therapies for Chronic Hepatitis B
    Ya-Chao Tao, Dongbo Wu, Lingyun Zhou, En‐Qiang Chen, Changhai Liu, Xiaoqiong Tang, Wei Jiang, Ning Han, Hong Li, Hong Tang · 2019 · Advances in experimental medicine and biology
  30. Advances of Nanoparticles for Leukemia Treatment
    Jie Shen, Zhiguo Lü, Jianze Wang, Tianlu Zhang, H. J. Yang, Yan Li, Guiying Liu, Xin Zhang · 2020 · ACS Biomaterials Science & Engineering
  31. Dose‐Independent Transfection of Hydrophobized Polyplexes
    Zhen Zhang, Nasha Qiu, Shuling Wu, Xin Liu, Zhuxian Zhou, Jianbin Tang, Yanpeng Liu, Ruhong Zhou, Youqing Shen · 2021 · Advanced Materials
  32. CRISPR/Cas9: at the cutting edge of hepatology
    Francis P. Pankowicz, Kelsey E. Jarrett, William R. Lagor, Karl‐Dimiter Bissig · 2017 · Gut
  33. Design of synthetic materials for intracellular delivery of RNAs: From siRNA-mediated gene silencing to CRISPR/Cas gene editing
    Jason B. Miller, Daniel J. Siegwart · 2018 · Nano Research
  34. CRISPR/Cas9 delivery by NIR-responsive biomimetic nanoparticles for targeted HBV therapy
    Dan Wang, Ling Chen, Li Chengbi, Quanxin Long, Qing Yang, Ailong Huang, Hua Tang · 2022 · Journal of Nanobiotechnology
  35. Extracellular vesicle‐mediated delivery of CRISPR/Cas9 ribonucleoprotein complex targeting proprotein convertase subtilisin‐kexin type 9 (Pcsk9) in primary mouse hepatocytes
    Nazma F. Ilahibaks, Thomas A. Kluiver, Olivier G. de Jong, Saskia C.A. de Jager, Raymond Michel Schiffelers, Pieter Vader, Weng Chuan Peng, Zhiyong Lei, Joost P. G. Sluijter · 2024 · Journal of Extracellular Vesicles
  36. CRISPR-Cas9: A method for establishing rat models of drug metabolism and pharmacokinetics
    Jian Lu, Jie Liu, Yuanqing Guo, Yuanjin Zhang, Yeye Xu, Xin Wang · 2021 · Acta Pharmaceutica Sinica B
  37. The status of extracellular vesicles as drug carriers and therapeutics
    Ameya Pravin Chaudhari, Omar M Budayr, Emily E. Bonacquisti, Caden C. Kussatz, Mark S. Bannon, Karissa J. Law, Yusha Liu, Matthew L. Bolton, Patrick M. Glassman, Leaf Huang et al. · 2026 · Nature Reviews Bioengineering
  38. Nano-vectors for CRISPR/Cas9-mediated genome editing
    Peng Yang, Athena Yue-Tung Lee, Jingjing Xue, Shih‐Jie Chou, Calvin Lee, Patrick Tseng, Tiffany X. Zhang, Yazhen Zhu, Junseok Lee, Shih‐Hwa Chiou et al. · 2022 · Nano Today
  39. In vivo therapeutic genome editing via CRISPR/Cas9 magnetoplexes for myocardial infarction
    Hanseul Park, Dongyoon Kim, Byounggook Cho, Junho Byun, Yong Sook Kim, Youngkeun Ahn, Jin Hur, Yu‐Kyoung Oh, Jongpil Kim · 2021 · Biomaterials
  40. Targeted delivery strategies: The interactions and applications of nanoparticles in liver diseases
    Xiandi Meng, Ge Zhu, Yong‐Guang Yang, Tianmeng Sun · 2024 · Biomedicine & Pharmacotherapy
  41. CRISPR/Cas-Dependent and Nuclease-Free In Vivo Therapeutic Gene Editing
    Ishani Dasgupta, Terence R. Flotte, Allison M. Keeler · 2021 · Human Gene Therapy
  42. Gene Targeting of HPV18 E6 and E7 Synchronously by Nonviral Transfection of CRISPR/Cas9 System in Cervical Cancer
    Kaijian Ling, Leiyan Yang, Neng Yang, Mengyue Chen, Yanzhou Wang, Liang Shi, Yudi Li, Lupin Jiang, Ping Yan, Zhiqing Liang · 2020 · Human Gene Therapy
  43. mRNA Delivery Using Bioreducible Lipidoid Nanoparticles Facilitates Neural Differentiation of Human Mesenchymal Stem Cells
    Xuewei Zhao, Zachary Glass, Jinjin Chen, Liu Yang, David Lee Kaplan, Qiaobing Xu · 2020 · Advanced Healthcare Materials
  44. mRNA delivery via non-viral carriers for biomedical applications
    Qi Shuai, Fangtao Zhu, Mengdan Zhao, Yunfeng Yan · 2021 · International Journal of Pharmaceutics
  45. Harnessing CRISPR to combat human viral infections
    H. Buhr, Robert Jan Lebbink · 2018 · Current Opinion in Immunology
  46. Charge-reversal nanocomolexes-based CRISPR/Cas9 delivery system for loss-of-function oncogene editing in hepatocellular carcinoma
    Jing‐Jun Nie, Yanli Liu, Qi Yu, Nasha Zhang, Bingran Yu, Dafu Chen, Ming Yang, Fu‐Jian Xu · 2021 · Journal of Controlled Release
  47. Synthetic Vehicles for Encapsulation and Delivery of CRISPR/Cas9 Gene Editing Machinery
    Valentina Carboni, Carine Maaliki, Mram Alyami, Shahad K. Alsaiari, Niveen M. Khashab · 2019 · Advanced Therapeutics
  48. Using CRISPR/Cas9 to model human liver disease
    Michele Alves‐Bezerra, Nika Furey, Collin G. Johnson, Karl‐Dimiter Bissig · 2019 · JHEP Reports
  49. A Review of Progress on Targeting LDL Receptor-Dependent and -Independent Pathways for the Treatment of Hypercholesterolemia, a Major Risk Factor of ASCVD
    Rai Ajit K. Srivastava · 2023 · Cells
  50. Anti-COVID-19 Nanomaterials: Directions to Improve Prevention, Diagnosis, and Treatment
    Mohammad Souri, Mohsen Chiani, Ali Akbar Farhangi, Mohammad Reza Mehrabi, Dariush Nourouzian, Kaamran Raahemifar, Madjid Soltani · 2022 · Nanomaterials
  51. Pre-clinical non-viral vectors exploited for in vivo CRISPR/Cas9 gene editing: an overview
    Nadia Rouatbi, Tasneem McGlynn, Khuloud T. Al‐Jamal · 2022 · Biomaterials Science
  52. Harnessing CRISPR technology for viral therapeutics and vaccines: from preclinical studies to clinical applications
    Farzaneh Zahedipour, Fatemeh Zahedipour, Parvin Zamani, Mahmoud Reza Jaafari, Amirhossein Sahebkar · 2024 · Virus Research
  53. Mutation-Directed Therapeutics for Neurofibromatosis Type I
    André Leier, David M. Bedwell, Ann T. Chen, George Dickson, Kim M. Keeling, Robert A. Kesterson, Bruce R. Korf, Tatiana T. Marquez‐Lago, Ulrich F. Müller, Linda J. Popplewell et al. · 2020 · Molecular Therapy — Nucleic Acids
  54. mRNA-based modalities for infectious disease management
    Mengjie Zhang, Abid Hussain, Haiyin Yang, Jinchao Zhang, Xing‐Jie Liang, Yuanyu Huang · 2022 · Nano Research
  55. Nonviral Nanoparticles for CRISPR-Based Genome Editing: Is It Just a Simple Adaption of What Have Been Developed for Nucleic Acid Delivery?
    Min Qiu, Zachary Glass, Qiaobing Xu · 2019 · Biomacromolecules
  56. Hepatocyte-confined CRISPR/Cas9-based nanocleaver precisely eliminates viral DNA for efficient and safe treatment of hepatitis B virus infection
    Huimin Kong, Chenya Zhuo, Ke Yi, Chunxiong Zheng, Rachel L. Mintz, Yeh‐Hsing Lao, Qingguo Zhong, Enguo Ju, Haixia Wang, Dan Shao et al. · 2023 · Nano Today
  57. Biomaterial-Based CRISPR/Cas9 Delivery Systems for Tumor Treatment
    Mengmeng Li, Fenglei Chen, Qian Yang, Qinglai Tang, Zian Xiao, Xinying Tong, Ying Zhang, Lanjie Lei, Shisheng Li · 2024 · Biomaterials Research
  58. Recent Progress and Future Prospective in HBV Cure by CRISPR/Cas
    Yu-Chan Yang, Hung‐Chih Yang · 2021 · Viruses
  59. Lipid-nanoparticle-enabled nucleic acid therapeutics for liver disorders
    Porkizhi Arjunan, Durga Kathirvelu, Gokulnath Mahalingam, Ashish Goel, Uday George Zacharaiah, Alok Srivastava, Srujan Kumar Marepally · 2024 · Acta Pharmaceutica Sinica B
  60. Probiotics Bi‐Enzymatic Cascade Repair System for Editing the Inflammatory Microenvironment to Boost Probiotic Therapy in Inflammatory Bowel Disease
    Jifeng Yu, Shaoyue Li, Bing Xiong, Yuting Shen, Xin‐Yuan Guan, Yuli Zhu, Fang Yan, Shen Zhang, Shi-Si Ding, Chang Liu et al. · 2024 · Advanced Materials
  61. Dual SORT LNPs for multi-organ base editing
    Minjeong Kim, Eunice S. Song, Joseph C. Chen, Sumanta Chatterjee, Yehui Sun, Sang M. Lee, Shiying Wu, Priyanka Patel, Zeru Tian, Ariel Kantor et al. · 2025 · Nature Biotechnology
  62. CRISPR and cardiovascular diseases
    Kiran Musunuru · 2022 · Cardiovascular Research
  63. Thermo‐triggered Release of CRISPR‐Cas9 System by Lipid‐Encapsulated Gold Nanoparticles for Tumor Therapy
    Peng Wang, Lingmin Zhang, Wenfu Zheng, Liman Cong, Zhaorong Guo, Yangzhouyun Xie, Le Wang, Rongbing Tang, Qiang Feng, Yoh Hamada et al. · 2017 · Angewandte Chemie
  64. Gene Editing for the Treatment of Hypercholesterolemia
    Menno Hoekstra, Miranda Van Eck · 2024 · Current Atherosclerosis Reports
  65. The potential of HBV cure: an overview of CRISPR-mediated HBV gene disruption
    Zhi Qiang Yao, Madison Schank, Juan Zhao, Mohamed El Gazzar, Ling Wang, Yi Zhang, Addison C. Hill, Puja Banik, Jaeden S. Pyburn, Jonathan P. Moorman · 2024 · Frontiers in Genome Editing
  66. Intelligent Design of Lipid Nanoparticles for Enhanced Gene Therapeutics
    Yichen Yuan, Ying Li, Guo Li, Liqun Lei, Xingxu Huang, Ming Li, Yuan Yao · 2025 · Molecular Pharmaceutics
  67. Efficient silencing of hepatitis B virus S gene through CRISPR‐mediated base editing
    Hao Zhou, Xiaomei Wang, Clifford J. Steer, Guisheng Song, Junqi Niu · 2022 · Hepatology Communications
  68. Recent advances in therapeutic CRISPR-Cas9 genome editing: mechanisms and applications
    Lifang Zhou, Shaohua Yao · 2023 · Molecular Biomedicine
  69. Advances in therapeutic application of CRISPR-Cas9
    Jin‐Yu Sun, Jianchu Wang, Donghui Zheng, Xiaorong Hu · 2019 · Briefings in Functional Genomics
  70. Nucleic acid vaccines for hepatitis B and C virus
    Samaneh Karimkhanilouei, ‪Saeid Ghorbian · 2019 · Infection Genetics and Evolution
  71. Gene editing in dermatology: Harnessing CRISPR for the treatment of cutaneous disease
    Catherine M. Baker, Matthew S. Hayden · 2020 · F1000Research
  72. Nonviral Delivery of CRISPR/Cas Systems in mRNA Format
    Zhen Liu, Zhenghua Li, Bin Li · 2022 · Advanced NanoBiomed Research
  73. CRISPRimmunity: an interactive web server for CRISPR-associated Important Molecular events and Modulators Used in geNome edIting Tool identifYing
    Fengxia Zhou, Xiaorong Yu, Rui Gan, Kuan Ren, Chuangeng Chen, Chunyan Ren, Meng Cui, Yuchen Liu, Yiyang Gao, Shouyu Wang et al. · 2023 · Nucleic Acids Research
  74. Nuclease-Mediated Gene Therapies for Inherited Metabolic Diseases of the Liver.
    Bryson Te, Caitlin M. Anglin, P. Hudson Bridges, Renee N. Cottle · 2017 · PubMed Central
  75. Synthetic gRNA/Cas9 ribonucleoprotein targeting HBV DNA inhibits viral replication
    Jinyu Zhang, Yi Zhang, Sushant Khanal, Dechao Cao, Juan Zhao, Xindi Dang, Lam Ngoc Thao Nguyen, Madison Schank, Xiao Y. Wu, Yong Jiang et al. · 2023 · Journal of Medical Virology
  76. Spatiotemporal Delivery of CRISPR/Cas9 Genome Editing Machinery Using Stimuli‐Responsive Vehicles
    Weiqi Cai, Tianli Luo, Lanqun Mao, Ming Wang · 2020 · Angewandte Chemie
  77. A comprehensive overview of CRISPR/Cas 9 technology and application thereof in drug discovery
    Amit Khurana, Nilofer Sayed, Vishakha Singh, Isha Khurana, Prince Allawadhi, Pushkar Singh Rawat, Umashanker Navik, Sravan Kumar Pasumarthi, Kala Kumar Bharani, Ralf Weiskirchen · 2022 · Journal of Cellular Biochemistry
  78. Polyrotaxane Nanocarriers Can Deliver CRISPR/Cas9 Plasmid to Dystrophic Muscle Cells to Successfully Edit the DMD Gene
    Michael R. Emami, Courtney S. Young, Ying Chao Ji, Xiangsheng Liu, Ekaterina I. Mokhonova, April D. Pyle, Huan Meng, Melissa J. Spencer · 2019 · Advanced Therapeutics
  79. Multivalent Peptide-Functionalized Bioreducible Polymers for Cellular Delivery of Various RNAs
    Dong‐Chu Yang, Alexander C. Eldredge, James C. Hickey, Hurik Muradyan, Zhibin Guan · 2020 · Biomacromolecules
  80. Canopy Homolog 2 contributes to liver oncogenesis by promoting unfolded protein response–dependent destabilization of tumor protein P53
    Feng Hong, Ching Ying Lin, Jingyue Yan, Yizhou Dong, Yuli Ouyang, Doyeon Kim, Xiaoli Zhang, Bei Liu, Shaoli Sun, Wei Jun Gu et al. · 2022 · Hepatology
  81. CRISPR/Cas9 for hepatitis B virus infection treatment
    Bo Cai, Shixue Chang, Yuhan Tian, Shuai Zhen · 2023 · Immunity Inflammation and Disease
  82. Current therapies for osteoarthritis and prospects of CRISPR-based genome, epigenome, and RNA editing in osteoarthritis treatment
    Yuxi Chen, Xiao Ling Luo, Rui Kang, Kaixin Cui, Jianping Ou, Xiya Zhang, Puping Liang · 2023 · Journal of genetics and genomics/Journal of Genetics and Genomics
  83. Harnessing CRISPR/Cas 9 System for manipulation of DNA virus genome
    Saeedeh Ebrahimi, Ali Teimoori, Hashem Khanbabaei, Maryam Tabasi · 2018 · Reviews in Medical Virology
  84. Hydrophobic Optimization of Functional Poly(TPAE-co-suberoyl chloride) for Extrahepatic mRNA Delivery following Intravenous Administration
    Xueliang Yu, Shuai Liu, Qiang Cheng, Sang M. Lee, Tuo Wei, Di Zhang, Lukas Farbiak, Lindsay T. Johnson, Xu Wang, Daniel J. Siegwart · 2021 · Pharmaceutics
  85. Current knowledge on the tissue distribution of mRNA nanocarriers for therapeutic protein expression
    Matthias Zadory, Elliot Lopez, Samuel Babity, Simon‐Pierre Gravel, Davide Brambilla · 2022 · Biomaterials Science
  86. Novel Approaches for the Treatment of Familial Hypercholesterolemia: Current Status and Future Challenges
    Long Jiang, Luya Wang, Xiaoshu Cheng · 2018 · Journal of Atherosclerosis and Thrombosis
  87. Debugging the genetic code: Non-viral in vivo delivery of therapeutic genome editing technologies
    Alexandra S. Piotrowski-Daspit, Peter M. Glazer, W. Mark Saltzman · 2018 · Current Opinion in Biomedical Engineering
  88. In vitro transcribed mRNA for expression of designer nucleases: Advantages as a novel therapeutic for the management of chronic HBV infection
    Abdullah Ely, Prashika Singh, Tiffany S. Smith, Patrick B. Arbuthnot · 2020 · Advanced Drug Delivery Reviews
  89. Clinical trials and promising preclinical applications of CRISPR/Cas gene editing
    Barış Çerçi, İhsan Alp Uzay, Mustafa Kemal Kara, Pervin Dinçer · 2022 · Life Sciences
  90. Genomic insights into heart health: Exploring the genetic basis of cardiovascular disease
    Mishal Safdar, Muneeb Ullah, Abdul Wahab, Shah Hamayun, Mahboob Ur Rehman, Muhammad Amir Khan, Shahid Ullah Khan, Aziz Ullah, Fakhar ud Din, Uzma Azeem Awan et al. · 2023 · Current Problems in Cardiology
  91. CRISPR to the Rescue: Advances in Gene Editing for the FMR1 Gene
    Carolyn M. Yrigollen, Beverly L. Davidson · 2019 · Brain Sciences
  92. Advances in Nanoparticle Drug Delivery Systems for Anti-Hepatitis B Virus Therapy: A Narrative Review
    Jing Miao, Peng Gao, Qian Li, Kaifeng He, Li‐wen Zhang, Junyan Wang, Lingfei Huang · 2021 · International Journal of Molecular Sciences
  93. Current Status of Nonviral Vectors for Gene Therapy in China
    Li Liu, H. J. Yang, Ke Men, Zhiyao He, Min Luo, Zhiyong Qian, Xiawei Wei, Yuquan Wei · 2018 · Human Gene Therapy
  94. Biosafety materials: Ushering in a new era of infectious disease diagnosis and treatment with the CRISPR/Cas system
    Yuquan Zhang, Ziyue Li, Julien Milon Essola, Kun Ge, Xuyan Dai, Huining He, Haihua Xiao, Yuhua Weng, Yuanyu Huang · 2022 · Biosafety and Health
  95. Development of New Genome Editing Tools for the Treatment of Hyperlipidemia
    Giulio Preta · 2023 · Cells
  96. Natural Biopolymer-Based Delivery of CRISPR/Cas9 for Cancer Treatment
    Meng Lin, Xueyan Wang · 2023 · Pharmaceutics
  97. Engineered PsCas9 enables therapeutic genome editing in mouse liver with lipid nanoparticles
    Dmitrii Degtev, Jack P. K. Bravo, Aikaterini Emmanouilidi, Aleksandar Zdravković, Oi Kuan Choong, Julia Liz Touza, Niklas Selfjord, Isabel Weisheit, Margherita Francescatto, Pınar Akçakaya et al. · 2024 · Nature Communications
  98. 多样化CRISPR技术在动物体内基因编辑研究中的应用和进展
    马迅, Xun Ma, 黄芯渝, 谭晞彦, 崔雍建, 钟礼瞬, 冯波, Avery Sum-Yu Wong, Hei-Yin Tam, Samuel Yung-Kin Tsui et al. · 2018 · 动物学研究
  99. Intracellular delivery of messenger RNA to macrophages with surfactant-derived lipid nanoparticles
    Yongzhuo Huang, Meifeng Yang, N. Wang, S. Li, Zhen Liu, Z. Li, Zi-Han Ji, Bin Li · 2022 · Materials Today Advances
  100. Magnetic‐Activated Nanosystem with Liver‐Specific CRISPR Nonviral Vector to Achieve Spatiotemporal Liver Genome Editing as Hepatitis B Therapeutics
    Chenya Zhuo, Huiming Kong, Ke Yi, Chun‐Wei Chi, Jiabin Zhang, Ran Chen, Haixia Wang, Caixia Wu, Yeh‐Hsing Lao, Yu Tao et al. · 2023 · Advanced Functional Materials